Zoryl-M 4 Forte Tablet PR

This fixed-dose formulation offers a synergistic effect, targeting multiple pathophysiological defects of type 2 diabetes. Zoryl-M 4 Forte Tablet PR is typically prescribed when diet, exercise, and monotherapy with either agent do not achieve adequate glycemic control. The extended-release formulation allows for once-daily dosing, improving patient compliance. It is essential to monitor blood glucose levels regularly and adjust the dosage based on therapeutic response and tolerability.

Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as the risk of hypoglycemia primarily due to Glimepiride. Caution is advised in patients with renal or hepatic impairment, and contraindications include severe renal dysfunction, metabolic acidosis, and hypersensitivity to the components. This medication should be used under strict medical supervision with appropriate lifestyle modifications to optimize diabetes management.